A Lactose-Based Kluyveromyces lactis Cell-Free Protein Synthesis System
Chem & Bio Engineering · 23.10.2025 · 2 (10) · 602-611
DOI: 10.1021/cbe.5c00011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chem & Bio Engineering, online erschienen am 09.07.2025. Verfasst von Tejasvi Shivakumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College Centre for Synthetic Biology, Imperial College London, SW7 2AZ London, U.K. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Defense Advanced Research Projects Agency, H2020 Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Yeasts have long been celebrated for their metabolic prowess, in particular, their ability to transform grain and fruit into valuable food products. In recent decades, humans have exploited them for pharmaceutical applications driven by advances in metabolic engineering and synthetic biology. Through convergence of these disciplines, this study highlights the development of a cell-free protein synthesis (CFPS) platform using Kluyveromyces lactis, a yeast prized for its role in the dairy industry. We present a workflow for preparing K. lactis extracts and incorporate lactose as a sustainable and cost-effective carbon source for biomass generation and as an energy source for CFPS. A semiautomated design-of-experiments (DoE) approach was undertaken, based on a Latin Hypercube experimental design, which tested 128 unique CFPS reaction mix compositions (against a baseline optimized for Pichia pastoris). The optimized reaction mix was validated by the synthesis of two model proteins: green fluorescent protein (deGFP) and Erythropoietin (EPO), which is a clinically relevant therapeutic. We identified conditions with 4-fold improvement in yield with the optimized reaction producing 54 nM of EPO. By integrating lactose-based growth, protein synthesis, and rational optimization strategies, this study sets the scene for developing yeast-based CFPS platforms tailored for diverse applications, from biosensor development to industrially relevant biopharmaceutical production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Imperial College Centre for Synthetic Biology, Imperial College London, SW7 2AZ London, U.K.
- Department of Chemical Engineering, Imperial College London, SW7 2AZ London, U.K.
- London Biofoundry, Imperial College Translation and Innovation Hub, Imperial College London, SW7 2AZ London, U.K.
- Department of Infectious Diseases, Imperial College London, SW7 2AZ London, U.K.
- Gingko Bioworks, Boston, Massachusetts 02210, United States.
ORCID-Profile: Tejasvi Shivakumar, Maria Victoria Bussoletti Panizo, Marko Storch, Paul S Freemont, Karen M Polizzi
Förderung
- Engineering and Physical Sciences Research Council
- Defense Advanced Research Projects Agency
- H2020 Marie Sklodowska-Curie Actions
Zitieren
APA
Shivakumar, T., Das, A., Bussoletti Panizo, M. V., Storch, M., Thavarajah, W., Freemont, P. S., & Polizzi, K. M. (2025). A Lactose-Based Kluyveromyces lactis Cell-Free Protein Synthesis System. Chem & Bio Engineering, 2(10), 602-611. https://doi.org/10.1021/cbe.5c00011
Vancouver
Shivakumar T, Das A, Bussoletti Panizo MV, Storch M, Thavarajah W, Freemont PS, et al. A Lactose-Based Kluyveromyces lactis Cell-Free Protein Synthesis System. Chem & Bio Engineering. 2025;2(10):602-611. doi:10.1021/cbe.5c00011
BibTeX
@article{Shivakumar2025,
author = {Shivakumar, Tejasvi and Das, Akashaditya and Bussoletti Panizo, Maria Victoria and Storch, Marko and Thavarajah, Walter and Freemont, Paul S and Polizzi, Karen M},
title = {A Lactose-Based Kluyveromyces lactis Cell-Free Protein Synthesis System},
journal = {Chem & Bio Engineering},
year = {2025},
volume = {2},
number = {10},
pages = {602--611},
doi = {10.1021/cbe.5c00011}
}
EUVIMED